Back in February when I first read about Pradaxa® [how many examples?…, foot-in-mouth disease…], I couldn’t help but comment even though it had nothing to do with psychiatry. Without even reading the articles, just the basic premise was suspicious – that Boehringer Ingelheim had introduced a "blood thinner" [anticoagulant] that didn’t have to be monitored with blood tests. After a medical lifetime of monitering people on Warfarin with monthly clotting tests, I couldn’t figure how one could achieve the same results with a medication that didn’t have to be monitored. And when I actually read the articles, I still couldn’t. To me, Pradaxa® is a nightmare. It is an anticoagulant that, unlike Warfarin, can’t be reversed if a person has a bleeding episode. Having spent plenty of nights in a former career pumping patients full of Vitamin K to reverse dangerous bleeding, I wondered what one was to do when a person on Pradaxa® slarted bleeding. I had a vision of the little Dutch Boy trying to stop leaks in the Dyke and running out of fingers.
by Cohen D.British Medical Journal. 2014; 349:g4670.
by Cohen D.British Medical Journal. 2014; 349:g4747.
by Charlton B and Redberg R.British Medical Journal. 2014; 349:g4681.
by Moore TJ, Cohen MR, and Mattison DR.British Medical Journal. 2014; 349:g4517.
Sorry, the comment form is closed at this time.